Skip to content
Explore the latest in gaming, tech, and entertainment with …

Administering Pluripotent Cells During Pregnancy to Infants with Neural Tube Defect Boosts Life Outcomes, Trial Finds

A pioneering research effort has discovered that providing pluripotent cells to unborn babies affected by spina bifida while undergoing fetal surgery could constitute a "major milestone" in treating birth defects.

Research Framework and Assurance

The US-based trial focused on six unborn babies with the 'open' form of spina bifida. Doctors administered placenta-derived mesenchymal stem cells directly onto the developing neural column while the defect was being closed.

Critically, the cell therapy demonstrated a favorable safety profile. Doctors verified that the cells did not cause cancerous growths, disrupt the healing process, or prevent the reversal of co-occurring hindbrain herniation.

Promising Outcomes

Magnetic resonance imaging performed on the newborns showed a full resolution of hindbrain herniation in all six infants. This favorable anatomical change is a key indicator for better mobility and function.

"In the event it allows additional babies capable of walking who previously could not, it could establish itself as their standard of care," commented the principal investigator. "The results are profoundly encouraging and open the door to lots of potential novel therapies."

Future Implications and Hope

Experts not involved in the trial proposed that additional validation of these noted improvements could signal a "different age" in prenatal intervention. The prospect of enhancing neural deficits present before birth is viewed as a revolutionary objective.

Notably important would be better management of bladder and bowel function, which are frequent complications for individuals living with this condition.

Looking Ahead

Although this preliminary study involved a limited number of patients, its established security and encouraging indicators provide a strong foundation for broader investigative efforts. The integration of stem cell therapy with proven prenatal surgical methods presents significant potential for improving the prognosis for future generations with this neural tube defect.

About the author

Eddie Ayers

A passionate gaming journalist and tech enthusiast with over a decade of experience covering industry trends and innovations across the UK.

PlayWorldPlus

Type to search articles.